RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.61x

RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) has a Cash Flow Reinvestment Rate of 0.61x as of December 2024, reinvesting €77.90 Million (capex €70.40 Million plus investments €7.50 Million) from operating cash flow of €127.60 Million. Explore RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.61x
(Capex + Investments) / Operating CF

Total Reinvested

€77.90 Million
Capex + Investments

Operating Cash Flow

€127.60 Million
EUR

Capital Expenditures

€70.40 Million
EUR

RHOEN-KLINIK.UNSP.ADR 1/2 Cash Flow Reinvestment Rate (2021–2024)

Historical reinvestment intensity for RHOEN-KLINIK.UNSP.ADR 1/2 across 4 annual periods. Also explore RHOEN-KLINIK.UNSP.ADR 1/2 total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)

Year-by-year capital reinvestment analysis for RHOEN-KLINIK.UNSP.ADR 1/2. For live market cap and broader valuation context, see RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 0.61x €77.90 Million €127.60 Million €70.40 Million ▼ -54.3%
2023 1.33x €145.50 Million €109.00 Million €62.80 Million ▼ -24.5%
2022 1.77x €106.60 Million €60.30 Million €58.20 Million ▲ +121.3%
2021 0.80x €77.90 Million €97.50 Million €77.80 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow